Main Content

I-5 Holdings Ltd.

Company Overview

About Us
I-5 is a Canadian company focused on the US recreational and medical Cannabis industry.

Our Mission
I-5 Holdings Ltd will be a leading consumer-driven company focused on delivering the highest quality Cannabis products and experiences.

The Strategy
I-5 Holdings Ltd will acquire profitable, established Cannabis focused companies that require capital to scale. Target acquisitions will be top quality operations with experienced management and defined business plans.

Market and Brand Opportunity

In this current early stage of the cannabis industry, there is a lack of established brands and a lack of focus on channel development.

As customer behavior matures and more options are available, accessibility, branding, marketing, and consistent quality will have a much higher impact on customer choices.

Core Assets

Mellow Extracts
Mellow Holdings are a “Service for Hire” extraction lab that assists brands and becomes their wholesale supply chain partner, exclusively when able. The vast majority of “labs” are trying to build a brand as their exclusive model (too risky and too expensive). Mellow will formulate products to the client’s specifications. Whether it’s a simple extraction of THC/CBD blends for vape cartridges or more complicated special purpose applications, the laboratory will supply the customer with what they require.Learn more

Medmen (Santa Ana)
Medmen is a Core Asset of I-5 Holdings Inc. with an 8,148 square foot facility located in Santa Ana, CA. This is the only city within Orange County to allow dispensaries and limited to 20 licenses. Orange County has over 3,000,000 residents. Medmen dispensaries maintain a track record of over 90% repeat medical customers and customers spend $20 more per visit than the Southern California average.
Learn more

Cascadia Gardens
Cascadia Gardens produces superior cannabis and creates infused products for recreational use from the rich region of the world, Bellingham, Washington USA. The tier 2 license is 10,000 sq. ft. capacity with 6,000 sq. ft. currently being utilized. Future plans involve expanding in the current location and acquiring a second license for the Cannabis Campus. Q3 2017 revenues are expected to exceed $200k USD per month with a 35% EBITDA margin.
Learn more